119 related articles for article (PubMed ID: 27073163)
1. DHX33 expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Tian QH; Zhang MF; Luo RG; Fu J; He C; Hu G; Zeng JS
Biochem Biophys Res Commun; 2016 May; 473(4):1163-1169. PubMed ID: 27073163
[TBL] [Abstract][Full Text] [Related]
2. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
3. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
[TBL] [Abstract][Full Text] [Related]
4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma.
Li C; Liao J; Wu S; Fan J; Peng Z; Wang Z
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):511-517. PubMed ID: 29106957
[TBL] [Abstract][Full Text] [Related]
8. LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis.
Tian M; Liu W; Jin L; Jiang X; Yang L; Ding Z; Shen Y; Peng Y; Gao D; Li L; Zhou J; Qiu S; Dai Z; Fan J; Shi Y
Int J Clin Exp Pathol; 2015; 8(4):3892-900. PubMed ID: 26097573
[TBL] [Abstract][Full Text] [Related]
9. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
10. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of the prognostic and immunological role of DHX33 in pan-cancer.
Ding J; Zhou J; Shen X; Zhang M; Feng X; Xu Z
Environ Toxicol; 2023 Aug; 38(8):2011-2021. PubMed ID: 37256545
[TBL] [Abstract][Full Text] [Related]
15. Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma.
Li N; Hu WJ; Shi J; Xue J; Guo WX; Zhang Y; Guan DX; Liu SP; Cheng YQ; Wu MC; Xie D; Liu SR; Cheng SQ
Asian Pac J Cancer Prev; 2013; 14(6):3509-14. PubMed ID: 23886137
[TBL] [Abstract][Full Text] [Related]
16. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
17. Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma.
Chen MH; Jan YH; Chang PM; Chuang YJ; Yeh YC; Lei HJ; Hsiao M; Huang SF; Huang CY; Chau GY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S616-24. PubMed ID: 23838921
[TBL] [Abstract][Full Text] [Related]
18. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of caprin1 expression is associated with poor prognosis in hepatocellular carcinoma.
Tan N; Dai L; Liu X; Pan G; Chen H; Huang J; Xu Q
Pathol Res Pract; 2017 Dec; 213(12):1563-1567. PubMed ID: 29037839
[TBL] [Abstract][Full Text] [Related]
20. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
